| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.54 | 0.06 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.22 | 0.06 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.32 | 0.07 |